Furthermore, tissue transglutaminase drives inflammation in CD, impairing the expression of peroxisome proliferator-activated receptor γ, which could be implicated in a decreased risk of T2DM [22]. This evidence concerns the gene TGM2 and type 2 diabetes mellitus.